|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.49 USD | -4.86% |
|
-7.23% | +67.51% |
| 18/05 | Astronova Inc - property value for settlement agreed at EUR 2.5 million - SEC filing | RE |
| 15/05 | Astronova agrees to settlement regarding MTEX acquisition | RE |
| Fiscal Period: January | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.63 | 3.02 | 5.22 | 2.67 | 2.42 | |||||
Return on Total Capital | 0.78 | 3.72 | 6.24 | 3.15 | 2.85 | |||||
Return On Equity % | 8.26 | 3.22 | 5.38 | -17.45 | -3.11 | |||||
Return on Common Equity | 8.26 | 3.22 | 5.38 | -17.45 | -3.11 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 35.78 | 33.79 | 36.25 | 34.87 | 32.51 | |||||
SG&A Margin | 28.8 | 24.69 | 23.93 | 26.56 | 24.35 | |||||
EBITDA Margin % | 4.38 | 7.06 | 10.56 | 7.1 | 6.84 | |||||
EBITA Margin % | 2.86 | 5.64 | 9.3 | 5.66 | 5.58 | |||||
EBIT Margin % | 0.98 | 4.31 | 7.68 | 3.94 | 3.65 | |||||
Income From Continuing Operations Margin % | 5.47 | 1.87 | 3.17 | -9.58 | -1.58 | |||||
Net Income Margin % | 5.47 | 1.87 | 3.17 | -9.58 | -1.58 | |||||
Net Avail. For Common Margin % | 5.47 | 1.87 | 3.17 | -9.58 | -1.58 | |||||
Normalized Net Income Margin | 0.09 | 1.8 | 3.65 | 0.96 | 0.73 | |||||
Levered Free Cash Flow Margin | -1.49 | -6.32 | 8.38 | 4.33 | 9.62 | |||||
Unlevered Free Cash Flow Margin | -1.16 | -5.6 | 9.51 | 5.63 | 11.05 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.02 | 1.12 | 1.09 | 1.09 | 1.06 | |||||
Fixed Assets Turnover | 9.06 | 10.32 | 9.92 | 8.84 | 8.81 | |||||
Receivables Turnover (Average Receivables) | 6.8 | 7.36 | 6.63 | 6.83 | 7.49 | |||||
Inventory Turnover (Average Inventory) | 2.33 | 2.2 | 1.93 | 2.09 | 2.23 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.18 | 2.13 | 2.58 | 1.68 | 1.84 | |||||
Quick Ratio | 1.27 | 0.68 | 0.93 | 0.57 | 0.6 | |||||
Operating Cash Flow to Current Liabilities | 0.07 | -0.08 | 0.42 | 0.1 | 0.31 | |||||
Days Sales Outstanding (Average Receivables) | 53.65 | 49.58 | 55.03 | 53.56 | 48.75 | |||||
Days Outstanding Inventory (Average Inventory) | 156.44 | 166.18 | 188.87 | 175.07 | 163.75 | |||||
Average Days Payable Outstanding | 32.68 | 28.27 | 33.76 | 29.26 | 27.74 | |||||
Cash Conversion Cycle (Average Days) | 177.42 | 187.49 | 210.14 | 199.37 | 184.76 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 12.7 | 36.59 | 24.86 | 64.05 | 52.22 | |||||
Total Debt / Total Capital | 11.27 | 26.79 | 19.91 | 39.04 | 34.31 | |||||
LT Debt/Equity | 11.06 | 14.93 | 11.59 | 27.17 | 26.34 | |||||
Long-Term Debt / Total Capital | 9.82 | 10.93 | 9.28 | 16.56 | 17.31 | |||||
Total Liabilities / Total Assets | 29.53 | 39.39 | 32.25 | 47.97 | 44.13 | |||||
EBIT / Interest Expense | 1.71 | 3.66 | 4.22 | 1.86 | 1.57 | |||||
EBITDA / Interest Expense | 8.36 | 6.27 | 5.97 | 3.47 | 3.14 | |||||
(EBITDA - Capex) / Interest Expense | 5.71 | 6.13 | 5.65 | 3.11 | 3.05 | |||||
Total Debt / EBITDA | 1.82 | 2.93 | 1.39 | 4.35 | 3.65 | |||||
Net Debt / EBITDA | 0.89 | 2.56 | 1.11 | 3.9 | 3.28 | |||||
Total Debt / (EBITDA - Capex) | 2.66 | 3 | 1.47 | 4.86 | 3.76 | |||||
Net Debt / (EBITDA - Capex) | 1.3 | 2.62 | 1.18 | 4.35 | 3.38 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 1.25 | 21.32 | 3.9 | 2.16 | -0.51 | |||||
Gross Profit, 1 Yr. Growth % | 1.64 | 14.55 | 11.48 | -1.74 | -3.4 | |||||
EBITDA, 1 Yr. Growth % | -38.81 | 95.32 | 55.46 | -31.3 | -4.15 | |||||
EBITA, 1 Yr. Growth % | -48.63 | 139.66 | 71.23 | -37.82 | -1.99 | |||||
EBIT, 1 Yr. Growth % | -52.49 | 431.4 | 85.12 | -47.56 | -7.88 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 400.7 | -58.61 | 76.4 | -408.67 | -83.6 | |||||
Net Income, 1 Yr. Growth % | 400.7 | -58.61 | 76.4 | -408.67 | -83.6 | |||||
Normalized Net Income, 1 Yr. Growth % | -92.47 | 2.41T | 110.44 | -73.22 | -24.4 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 388.89 | -59.09 | 75 | -406.35 | -83.83 | |||||
Accounts Receivable, 1 Yr. Growth % | -1.67 | 26.13 | 6.75 | -7.97 | -10.52 | |||||
Inventory, 1 Yr. Growth % | 15.13 | 48.3 | -9.65 | 3.28 | -9.69 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -6.46 | 20.32 | -1.95 | 31.32 | -5.58 | |||||
Total Assets, 1 Yr. Growth % | -0.45 | 21.1 | -4.28 | 9.26 | -5.51 | |||||
Tangible Book Value, 1 Yr. Growth % | 22.99 | -2.37 | 17.2 | -33.61 | 5.91 | |||||
Common Equity, 1 Yr. Growth % | 8.47 | 4.14 | 7.01 | -16.1 | 1.47 | |||||
Cash From Operations, 1 Yr. Growth % | -91.03 | -310.62 | -520.78 | -60.76 | 142.12 | |||||
Capital Expenditures, 1 Yr. Growth % | -30.58 | -87.25 | 282.1 | 33.14 | -71.5 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -112.98 | 415.35 | -237.85 | -47.29 | 121.26 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -109.79 | 483.31 | -276.35 | -39.48 | 95.13 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | - | - | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -6.17 | 10.83 | 12.27 | 3.03 | 0.82 | |||||
Gross Profit, 2 Yr. CAGR % | -7.15 | 7.9 | 10.79 | 4.66 | -0.58 | |||||
EBITDA, 2 Yr. CAGR % | -23.14 | 9.33 | 37.68 | 3.34 | -11.21 | |||||
EBITA, 2 Yr. CAGR % | -28.87 | 10.96 | 46.06 | 3.18 | -13.42 | |||||
EBIT, 2 Yr. CAGR % | -31.07 | 58.9 | 63.46 | -1.48 | -20.98 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 91.18 | 43.96 | -14.55 | 133.34 | -28.85 | |||||
Net Income, 2 Yr. CAGR % | 91.18 | 43.96 | -14.55 | 133.34 | -28.85 | |||||
Normalized Net Income, 2 Yr. CAGR % | -65.4 | 37.34 | 62.78 | -24.93 | -46.3 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 91.49 | 41.42 | -15.39 | 131.54 | -29.62 | |||||
Accounts Receivable, 2 Yr. CAGR % | -6.97 | 11.36 | 16.04 | -0.88 | -9.26 | |||||
Inventory, 2 Yr. CAGR % | 1 | 30.67 | 15.75 | -3.4 | -3.42 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -1.54 | 6.09 | 8.62 | 13.47 | 5.93 | |||||
Total Assets, 2 Yr. CAGR % | -0.74 | 9.8 | 7.66 | 2.27 | 1.61 | |||||
Tangible Book Value, 2 Yr. CAGR % | 20.92 | 9.58 | 6.96 | -11.79 | -18.23 | |||||
Common Equity, 2 Yr. CAGR % | 6.54 | 6.29 | 5.57 | -5.24 | -7.73 | |||||
Cash From Operations, 2 Yr. CAGR % | -34.24 | -56.54 | 197.7 | 28.5 | -2.52 | |||||
Capital Expenditures, 2 Yr. CAGR % | -21.39 | -70.25 | -30.2 | 125.55 | -38.4 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -9.93 | -18.2 | 708.61 | -14.76 | 15.76 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -26.48 | -24.44 | 397.4 | 3.31 | 15.48 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | - | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -4.92 | 2.22 | 8.47 | 8.79 | 1.83 | |||||
Gross Profit, 3 Yr. CAGR % | -8.01 | -0.41 | 9.08 | 6.44 | 0.54 | |||||
EBITDA, 3 Yr. CAGR % | -29.78 | 4.89 | 22.94 | 9.2 | 0.78 | |||||
EBITA, 3 Yr. CAGR % | -36.03 | 6.64 | 28.22 | 9.87 | 1.43 | |||||
EBIT, 3 Yr. CAGR % | -49.01 | 36.17 | 67.2 | 11.9 | -3.66 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 3.91 | 14.8 | 54.05 | 31.11 | -3.71 | |||||
Net Income, 3 Yr. CAGR % | 3.91 | 14.8 | 54.05 | 31.11 | -3.71 | |||||
Normalized Net Income, 3 Yr. CAGR % | -71.79 | 44.22 | 58.33 | -10.81 | -24.75 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 2.8 | 14.47 | 51.83 | 29.92 | -4.65 | |||||
Accounts Receivable, 3 Yr. CAGR % | -10 | 2.97 | 9.8 | 7.41 | -4.21 | |||||
Inventory, 3 Yr. CAGR % | 4.69 | 14.8 | 15.55 | 11.44 | -5.54 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 6.49 | 5.27 | 3.34 | 15.71 | 3.24 | |||||
Total Assets, 3 Yr. CAGR % | -1.14 | 6.07 | 4.89 | 8.19 | -0.39 | |||||
Tangible Book Value, 3 Yr. CAGR % | 21.37 | 12.6 | 12.06 | -8.76 | -7.8 | |||||
Common Equity, 3 Yr. CAGR % | 5.1 | 5.73 | 6.53 | -2.21 | -3.06 | |||||
Cash From Operations, 3 Yr. CAGR % | -34.69 | -3.07 | -7.37 | 51.51 | 58.71 | |||||
Capital Expenditures, 3 Yr. CAGR % | -16.14 | -57.13 | -30.33 | -13.44 | 13.18 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -22.58 | 61.09 | -2.66 | 225.42 | 17.15 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -31.03 | 46.64 | 0.23 | 146.48 | 27.7 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | - | - | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.6 | 4.68 | 1.62 | 2.54 | 5.34 | |||||
Gross Profit, 5 Yr. CAGR % | 1.26 | 1.82 | -0.12 | 1.59 | 3.42 | |||||
EBITDA, 5 Yr. CAGR % | -11.17 | 1.35 | 1.01 | 4.27 | 4.12 | |||||
EBITA, 5 Yr. CAGR % | -15.04 | 1.11 | 1.44 | 5.24 | 5.14 | |||||
EBIT, 5 Yr. CAGR % | -30.01 | 2.57 | 5.45 | 19.64 | 17.69 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 8.74 | -4.13 | -3.91 | 52.46 | 13.1 | |||||
Net Income, 5 Yr. CAGR % | 8.74 | -4.13 | -3.91 | 52.46 | 13.1 | |||||
Normalized Net Income, 5 Yr. CAGR % | -52.36 | -4.44 | 3.43 | 11.07 | -4.28 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 9.46 | -5.19 | -4.9 | 51.73 | 11.63 | |||||
Accounts Receivable, 5 Yr. CAGR % | 1.75 | -0.73 | -0.37 | 1.41 | 1.74 | |||||
Inventory, 5 Yr. CAGR % | 12.15 | 13.2 | 8.98 | 7.14 | 7.55 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.2 | 9.11 | 7.34 | 8.48 | 4.37 | |||||
Total Assets, 5 Yr. CAGR % | 6.56 | 2.62 | 2.29 | 4.53 | 3.56 | |||||
Tangible Book Value, 5 Yr. CAGR % | -3.95 | 23.3 | 15.39 | 2.12 | -1.21 | |||||
Common Equity, 5 Yr. CAGR % | 2.81 | 5.8 | 5.29 | 1.2 | 0.58 | |||||
Cash From Operations, 5 Yr. CAGR % | -27.49 | -4.64 | 19.81 | 8.5 | -5.46 | |||||
Capital Expenditures, 5 Yr. CAGR % | 7.73 | -57.78 | -22.07 | -16.71 | -33.68 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -22.97 | -9.16 | 26.94 | 24.88 | 1.47 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -26.64 | -11.06 | 27.54 | 27.47 | 3.52 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | - | - |
- Stock Market
- Equities
- ALOT Stock
- Financials AstroNova, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















